Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
DESCRIPTION (provided by applicant): The proposed project will prepare the applicant for a career as an independent research scientist investigating the neurochemical mechanisms that underlie the motivational and reinforcing aspects of alcohol-directed behaviors. Alcohol-directed behaviors can be conceptually divided into two phases: 1) appetitive or alcohol seeking and 2) consumption or alcohol drinking. It is hypothesized that activation of the GAB A receptor system exerts ethanol-directed behavior, The overall goal of this proposal is to examine whether midbrain GAB A (A) and (B) receptor systems modulate mesolimbic dopamine during the two phases of alcohol drinking behavior: seeking and consumption. Together these two components regulate alcohol intake and although certain aspects of their function may overlap in humans, they can be studied independently in a rodent model. Mesolimbic pathways from the ventral tegmental area to the nucleus accumbens (NAc) and central nucleus of the amygdala (Amg) have a major role in regulating both the motivational and consummatory behaviors related to alcohol use.
However, changes in the level of mesolimbic dopamine in these brain regions have only been investigated during the drinking phase. Extracellular levels of dopamine will be evaluated in the nucleus accumbens and central nucleus of the amygdala. Aim 1 (rats and mice) will characterize the pattern of change of dopamine during ethanol seeking and consumption. Aim 2 (rats) will examine the role of GABA (A) and (B) receptor agonist effects on dopamine levels during ethanol seeking and consumption. Aim 3 will examine dopamine levels in GABA (A) receptor alpha knockout mice during alcohol seeking and consumption. The mentoring team will be comprised of leaders in alcohol and addiction research and the proposed research and career development plan will provide extensive training including the theoretical and practical aspects of operant conditioning, and utilization of in vivo microdialysis and HPLC for the assessment of extracellular dopamine levels in an across species paradigm. This novel approach will characterize the circuitry and specific neurotransmitter systems involved in ethanol-directed behaviors. These findings may lead to a pharmacological treatment that will attenuate alcohol "craving" and alcohol drinking. The project will assess the motivational and reinforcing aspects of alcohol underlying neurocircuitry and receptor mechanisms that will recipitate the planning of an RO1.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
GABA receptoralcoholic beverage consumptionamygdalabehavioral /social science research tagcravingdopamineethanolhigh performance liquid chromatographylaboratory mouselaboratory ratmicrodialysismicroinjectionsneuropharmacologyneuropsychologynucleus accumbensreinforcerspecies differencesubstance abuse related behavior
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
271
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
25-September-2005
Project End Date
31-August-2010
Budget Start Date
25-September-2005
Budget End Date
31-August-2006
Project Funding Information for 2005
Total Funding
$147,797
Direct Costs
$138,337
Indirect Costs
$9,460
Year
Funding IC
FY Total Cost by IC
2005
National Institute on Alcohol Abuse and Alcoholism
$147,797
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1K01AA015194-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K01AA015194-01A1
Patents
No Patents information available for 1K01AA015194-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K01AA015194-01A1
Clinical Studies
No Clinical Studies information available for 1K01AA015194-01A1
News and More
Related News Releases
No news release information available for 1K01AA015194-01A1
History
No Historical information available for 1K01AA015194-01A1
Similar Projects
No Similar Projects information available for 1K01AA015194-01A1